Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASND Ascendis Pharma A/S

休市中 08-23 16:00:00 EDT

139.68

+0.29

+0.21%

盘后139.68

+0.000.00%

19:41 EDT

最高144.62	最低137.63	成交量23.74万
今开139.66	昨收139.39	日振幅5.01%
总市值80.11亿	流通市值79.49亿	总股本5,735万
成交额3,304万	换手率0.42%	流通股本5,691万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":139.68,"timestamp":1724443200000,"preClose":139.39,"halted":0,"volume":237439,"hourTrading":{"tag":"盘后","latestPrice":139.68,"preClose":139.68,"latestTime":"19:41 EDT","volume":18253,"amount":2549593.5,"timestamp":1724456511182},"delay":0,"floatShares":56906612,"shares":57349754,"eps":-9.57998,"marketStatus":"休市中","marketStatusCode":7,"change":0.29,"latestTime":"08-23 16:00:00 EDT","open":139.66,"high":144.6182,"low":137.63,"amount":33038378.4233,"amplitude":0.050134,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.57998,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":1,"listingDate":1422421200000,"adjPreClose":139.39,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":140,"preClose":139.39,"latestTime":"09:14 EDT","volume":125,"amount":17500,"timestamp":1724418893576},"postHourTrading":{"tag":"盘后","latestPrice":139.68,"preClose":139.68,"latestTime":"19:41 EDT","volume":18253,"amount":2549593.5,"timestamp":1724456511182},"volumeRatio":0.5244230629158846,"impliedVol":0.407,"impliedVolPercentile":0.0833},"requestUrl":"/m/hq/s/ASND/tweets","defaultTab":"tweets","newsList":[{"id":"2461009825","title":"美国研究综述-Agree Realty、Global Payments、Snowflake","url":"https://stock-news.laohu8.com/highlight/detail?id=2461009825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461009825?lang=zh_cn&edition=full","pubTime":"2024-08-21 21:23","pubTimestamp":1724246592,"startTime":"0","endTime":"0","summary":"    路透8月21日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Agree Realty、Global Payments 和 Snowflake。要闻  * Agree Realty Corp   ：雷蒙德-詹姆斯将目标价从70美元上调至81美元 * Coinbase Global Inc   ：杰富瑞将目标价从245美元下调至220美元 * Global Payments Inc   ：杰富瑞将目标价从 120 美元上调至 130 美元 * Quest Diagnostics Inc   ：摩根大通将目标价从155美元上调至173美元 * Snowflake Inc   ：贝尔德将目标价从200美元下调至165美元 以下是路透周三报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPR","LU0310800965.SGD","CPB","EPRT","LU0211328371.USD","GNL","BMRN","CAH","COIN","COR","CX","CDNA","CHRD","ADC","EOSE","FCPT","AEO","BK4196","LU1861559042.SGD","COTY","ACIW","ASND","DOCS","EQIX","CIFR","GLPI","SNOW","DNMR","BV","CHWY","CIVI","BK4205","IE0004445015.USD","LU1861558580.USD","LU2552382215.SGD","ADSK","FIVN","LU0011850046.USD","CCOI","ATI","AXP","PINE","CI","DEI","BK4585","AADI","BOC","GLW","DBRG"],"gpt_icon":1},{"id":"2459190029","title":"Ascendis Pharma A/S盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459190029","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459190029?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:48","pubTimestamp":1723560486,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时48分，Ascendis Pharma A/S股票出现波动，股价急速拉升5.00%。截至发稿，该股报134.90美元/股，成交量10.5394万股，换手率0.18%，振幅4.51%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.73%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813224807a1d43418&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813224807a1d43418&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0109394709.USD","BK4139","LU0889565916.HKD","BK4585","ASND"],"gpt_icon":0},{"id":"2458856859","title":"Ascendis Pharma A/S盘中异动 快速上涨7.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458856859","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458856859?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:32","pubTimestamp":1723469543,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时32分，Ascendis Pharma A/S股票出现波动，股价急速上涨7.95%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Oragenics Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Revance Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为39.84%、19.87%、8.54%，振幅较大的相关个股有Oragenics Inc.、Sangamo Therapeutics, Inc.、Abcellera Biologics Inc.，振幅分别为23.21%、22.55%、12.69%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122132239592951b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122132239592951b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","ASND","BK4139","LU0889565916.HKD","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2456238657","title":"Ascendis Pharma A/S盘中异动 早盘股价大跌5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456238657","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456238657?lang=zh_cn&edition=full","pubTime":"2024-08-02 22:24","pubTimestamp":1722608684,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日22时24分，Ascendis Pharma A/S股票出现波动，股价急速跳水5.27%。截至发稿，该股报129.33美元/股，成交量5.0792万股，换手率0.09%，振幅4.17%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为2.48%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802222444968234cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802222444968234cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","ASND","BK4139"],"gpt_icon":0},{"id":"2446784604","title":"Ascendis Pharma A/S盘中异动 早盘快速上涨6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446784604","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446784604?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:30","pubTimestamp":1719322248,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时30分，Ascendis Pharma A/S股票出现异动，股价快速拉升6.58%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大，Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为84.60%、75.49%、56.15%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Allarity Therapeutics, Inc.、Glycomimetics, Inc.，振幅分别为12.48%、6.65%、6.04%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213048aef686cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213048aef686cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASND","BK4585","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2445379438","title":"Ascendis Pharma A/S盘中异动 临近收盘股价大涨5.24%报127.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445379438","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445379438?lang=zh_cn&edition=full","pubTime":"2024-06-22 03:51","pubTimestamp":1718999495,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日03时51分，Ascendis Pharma A/S股票出现波动，股价大幅拉升5.24%。截至发稿，该股报127.99美元/股，成交量22.7088万股，换手率0.40%，振幅5.19%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.13%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622035135aef6105c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622035135aef6105c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4585","BK4139","ASND","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2442556313","title":"Ascendis Pharma A/S盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442556313","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442556313?lang=zh_cn&edition=full","pubTime":"2024-06-12 22:41","pubTimestamp":1718203300,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日22时41分，Ascendis Pharma A/S股票出现波动，股价急速下跌5.02%。截至发稿，该股报125.31美元/股，成交量13.6025万股，换手率0.24%，振幅6.58%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.94%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612224140941ee19c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612224140941ee19c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","ASND","BK4585"],"gpt_icon":0},{"id":"2439964835","title":"Ascendis Pharma A/S：Stifel以买入评级和200美元目标股价启动报道","url":"https://stock-news.laohu8.com/highlight/detail?id=2439964835","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439964835?lang=zh_cn&edition=full","pubTime":"2024-05-31 18:52","pubTimestamp":1717152739,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0109394709.USD","ASND","LU0889565916.HKD","LU0320765992.SGD","BK4139","BK4585"],"gpt_icon":0},{"id":"2439966568","title":"Ascendis Pharma(ASND.US)获Stifel首次覆盖，给予买入评级, 目标价200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2439966568","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2439966568?lang=zh_cn&edition=full","pubTime":"2024-05-31 18:03","pubTimestamp":1717149809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","ASND","BK4585"],"gpt_icon":0},{"id":"2437029004","title":"Ascendis Pharma A/S盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437029004","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437029004?lang=zh_cn&edition=full","pubTime":"2024-05-22 23:37","pubTimestamp":1716392225,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日23时37分，Ascendis Pharma A/S股票出现异动，股价快速上涨5.05%。截至发稿，该股报129.06美元/股，成交量43.5482万股，换手率0.76%，振幅5.05%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.45%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522233705af89b16c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522233705af89b16c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","ASND","BK4139","LU0889565916.HKD","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2436607300","title":"大摩：维持Ascendis Pharma(ASND.US)评级，由持股观望调整至持股观望评级, 目标价由116.00美元调整至140.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2436607300","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436607300?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:15","pubTimestamp":1715876133,"startTime":"0","endTime":"0","summary":"大摩：维持Ascendis Pharma(ASND.US)评级，由持股观望调整至持股观望评级, 目标价由116.00美元调整至140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170015388b0f852e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170015388b0f852e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2436604008","title":"大摩：维持Ascendis Pharma(ASND.US)评级，由持股观望调整至持股观望评级, 目标价由116.00美元调整至140.","url":"https://stock-news.laohu8.com/highlight/detail?id=2436604008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436604008?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:00","pubTimestamp":1715875241,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0971096721.USD","LU0320765646.SGD","LU0320765992.SGD","LU0889565916.HKD","LU1074936037.SGD","LU1162221912.USD","LU0098860793.USD","LU0109394709.USD","BK4127","BK4585","BK4504","BK4139","BK4581","ASND","LU1668664300.SGD","IE00BZ1G4Q59.USD","LU0106831901.USD","BK4534","IE00BKVL7J92.USD","BK4588","LU1363072403.SGD","LU1989772923.USD","LU1989772840.SGD"],"gpt_icon":0},{"id":"2435527420","title":"成分股Harrow Health收涨34.55%领跑Humacyte涨17.15%Pacific Biosciences of California、23Andme Holding Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435527420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435527420?lang=zh_cn&edition=full","pubTime":"2024-05-15 05:50","pubTimestamp":1715723441,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PACB","BCRX","LU0109394709.USD","LU0320765992.SGD","BK4547","LU0889565916.HKD","LENZ","RAPT","SANA","BK4585","BK4121","BK4139","BK4568","BK4588","NVAX","ASND"],"gpt_icon":0},{"id":"2435052977","title":"成分股Harrow Health收涨34.55%领跑，Humacyte涨17.15%，Pacific Biosciences of California、23Andme Holding Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2435052977","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435052977?lang=zh_cn&edition=full","pubTime":"2024-05-15 05:47","pubTimestamp":1715723276,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BCRX","BK4547","BK4121","NVAX","RAPT","LU0320765992.SGD","BK4139","BK4568","LENZ","LU0109394709.USD","BK4585","LU0889565916.HKD","BK4588","ASND","SANA","PACB"],"gpt_icon":0},{"id":"2435554449","title":"Ascendis Pharma A/S盘中异动 下午盘股价大跌5.30%报125.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435554449","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435554449?lang=zh_cn&edition=full","pubTime":"2024-05-15 02:32","pubTimestamp":1715711567,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日02时32分，Ascendis Pharma A/S股票出现异动，股价快速下跌5.30%。截至发稿，该股报125.03美元/股，成交量33.0428万股，换手率0.58%，振幅5.47%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.17%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051502324787e87dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051502324787e87dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","ASND","BK4139","LU0889565916.HKD","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2432182825","title":"富国银行：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由260.00美元调整至262.","url":"https://stock-news.laohu8.com/highlight/detail?id=2432182825","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432182825?lang=zh_cn&edition=full","pubTime":"2024-05-04 02:02","pubTimestamp":1714759351,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0109394709.USD","ASND","LU0889565916.HKD","LU0320765992.SGD","BK4139","BK4585"],"gpt_icon":0},{"id":"2432904334","title":"坎托菲茨杰拉德公司：重申Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价173.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432904334","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432904334?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:05","pubTimestamp":1714748732,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价173.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032305348b70aca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032305348b70aca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2424719805","title":"坎托菲茨杰拉德公司：重申Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价173.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2424719805","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2424719805?lang=zh_cn&edition=full","pubTime":"2024-04-01 20:34","pubTimestamp":1711974883,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ASND","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"2422535118","title":"维升药业三冲港交所IPO：增高针数据不及竞品前景待考","url":"https://stock-news.laohu8.com/highlight/detail?id=2422535118","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2422535118?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:50","pubTimestamp":1711331414,"startTime":"0","endTime":"0","summary":"失之毫厘，差之千里？","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/content_default_5.jpg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/content_default_5.jpg"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3711208","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3711208","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["IE00BD4GTW91.USD","LU0109394709.USD","ASND","LU0889565916.HKD","BMRN","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4566","BK4588","LU0320765992.SGD","IE00BD4GTT62.SGD","BK4139","CNP","IE0002270589.USD","IE00B7SZLL34.SGD","IE00BD4GTV84.USD","BK4585","BK4208"],"gpt_icon":0},{"id":"2419975017","title":"富国银行：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由196.00美元调整至260.","url":"https://stock-news.laohu8.com/highlight/detail?id=2419975017","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419975017?lang=zh_cn&edition=full","pubTime":"2024-03-15 20:41","pubTimestamp":1710506482,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["ASND","BK4585","LU0889565916.HKD","LU0320765992.SGD","BK4139","LU0109394709.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascendispharma.com","stockEarnings":[{"period":"1week","weight":0.0061},{"period":"1month","weight":0.0423},{"period":"3month","weight":0.0711},{"period":"6month","weight":-0.1237},{"period":"1year","weight":0.457},{"period":"ytd","weight":0.109}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司，该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品，TransCon人生长激素或生长激素TransCon，每周一次给药治疗生长激素缺乏症以及其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037189},{"month":2,"riseRate":0.5,"avgChangeRate":0.037735},{"month":3,"riseRate":0.5,"avgChangeRate":0.039038},{"month":4,"riseRate":0.3,"avgChangeRate":-0.046884},{"month":5,"riseRate":0.4,"avgChangeRate":0.000611},{"month":6,"riseRate":0.6,"avgChangeRate":0.017012},{"month":7,"riseRate":0.6,"avgChangeRate":-0.000153},{"month":8,"riseRate":0.7,"avgChangeRate":0.082386},{"month":9,"riseRate":0.555556,"avgChangeRate":0.037325},{"month":10,"riseRate":0.444444,"avgChangeRate":0.006164},{"month":11,"riseRate":0.777778,"avgChangeRate":0.039978},{"month":12,"riseRate":0.444444,"avgChangeRate":0.049536}],"exchange":"NASDAQ","name":"Ascendis Pharma A/S","nameEN":"Ascendis Pharma A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ascendis Pharma A/S,ASND,Ascendis Pharma A/S股票,Ascendis Pharma A/S股票老虎,Ascendis Pharma A/S股票老虎国际,Ascendis Pharma A/S行情,Ascendis Pharma A/S股票行情,Ascendis Pharma A/S股价,Ascendis Pharma A/S股市,Ascendis Pharma A/S股票价格,Ascendis Pharma A/S股票交易,Ascendis Pharma A/S股票购买,Ascendis Pharma A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况